May 5, 2022
Pediatric Drug Therapy 2020 | Updates from the 2017 AAP Guidelines for Childhood HTN
Pediatric Drug Therapy 2020
Updates on the 2017 AAP Guidelines for Childhood HTN
Kelsey Pearson, MMS, PA-C
Physician Assistant, Nephrology, Seattle Children’s Hospital
For pediatric nurse practitioners, family nurse practitioners, physician assistants, clinical nurse specialists, nurses, respiratory therapists, pharmacists and other interested healthcare professionals.
Objectives for Learning Outcomes
At the conclusion of this activity, participants will be better able to:
- Review relevant information from the Fourth Report on the diagnosis, evaluation and treatment of high blood pressure in children and adolescents.
- Discuss the changes in the new guidelines published in 2017.
- Determine how the new guidelines will affect management of children with high blood pressure and discuss pharmacologic options.